Corrigendum to "In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis" [Int. J. Pharm. 535 (2018) 113-119].

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International journal of pharmaceutics

• Publication date

  2018-07-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijpharm.2018.06.045PMID 29983223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Pharmacokinetics of intranasal drugs, still a missed opportunity?

  2024cites this paper
• 鼻腔药物递送的影响因素和提高递送效率的设计策略

  2023cites this paper
• Paclitaxel Delivery to the Brain for Glioblastoma Treatment

  2023cites this paper
• A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin.

  2023cites this paper